BioTuesdays

Category - News

Agile Therapeutics
Markets

Maxim ups Agile Therapeutics PT to $8 from $3

Maxim Group raised its price target for Agile Therapeutics (NASDAQ:AGRX) to $8 from $3 after the FDA approved the company’s weekly contraceptive patch, Twirla. The stock closed at $4.07 on Feb. 14. Agile shares...

February 18, 2020
Co-Diagnostics
Markets

Maxim ups Co-Diagnostics PT to $5 from $2

Maxim Group raised its price target for Co-Diagnostics (NASDAQ:CODX) to $5 from $2, citing the company’s rapid development of a coronavirus test. The stock closed at $3.32 on Feb. 14. Analyst Jason McCarthy writes that...

February 18, 2020
Acasti Pharma
Markets

HCW halves Acasti Pharma PT to $3 from $6

H.C. Wainwright halved its price target for Acasti Pharma (NASDAQ:ACST) to $3 from $6 in light of the continued uncertainty around the company’s TRILOGY 1 and TRILOGY 2 trials. The stock closed at 57 cents on Feb. 14...

February 18, 2020
Sensus Healthcare Logo
Markets

AGP ups Sensus Healthcare to buy; PT $6

Alliance Global Partners upgraded Sensus Healthcare (NASDAQ:SRTS) to “buy” from “neutral” with a price target of $6 after the company reported fourth quarter results. The stock closed at $4.62 on Feb. 13. Analyst Ben...

February 14, 2020
Developments

Soligenix gets fast track designation for RiVax

The FDA granted fast track designation to Soligenix’s (NASDAQ:SNGX) RiVax for the prevention of ricin intoxication. Ricin is a lethal plant-derived toxin whose stability and high potency make it a potential biological...

February 13, 2020